Obesity Obstructive Sleep Apnea
Conditions
Interventions
Multimodal-telemonitoring Group 1. At the baseline visit, mobile health (mHealth) devices, namely the electrical weight scale, sphygmomanometer and pedometer will be provided to a participant. Attend
smartphone without using mHealth telemonitoring system. 6. When the physicians see the participants in person, after checking these data, the physicians will instruct the participants to (1) optimiz
Sponsors
Respiratory Care and Sleep Contorol Medicine, Graduate School of Medicine, Kyoto University
1.Tohoku university Hospital 2.Fukushima Medical University Hospital 3.Jichi Medical University Hospital 4.Juntendo University Hospital 5.Nihon university Hospital 6.Tokyo Medical University Hospital 7.Jikei Medical universtiy Hospital 8.Shinjuku Sleep and Respiratory Clinic 9.Toranomon Hospital 10. Chiba University Hospital 11. Nishi-Niigata Chuo National Hospital 12. National Hospital Organization Minami Kyoto Hospital 13. Takatsuki Red Cross Hospital 14. Osaka Kaisei Hospital 15
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Body mass index is more than or equal to 25 kg/m2 2. Apnea hypopnea index is more than or equal to 20/h by polysomnography or Respiratory event index is more than equal to 40/h by a portable monitoring device at OSA diagnosis 3. Visiting the clinic/hospital every month or every two months for the management of CPAP treatment based on the government health insurance rule. 4. The attending physician can confirm the patient's CPAP adherence at the study enrollment. 5. Patients owning a smartphone or tablet with Bluetooth function. 6. CPAP was implemented more than or equal to 1 month previously.
Exclusion criteria
Exclusion criteria: 1.Secondary obesity (Obesity because of medication and endocrine disorder) 2.Impaired cognition 3.Chronic diseases affecting body weight (e.g. active malignancy and collagen diseases) 4.Dialysis 5.Body weight is more than or equal to 135kg (The Weight scale provided in this study cannot measure precisely for these patients.) 6.Attending physician recognize that exercise therapy cannot be recommended (BP >180/100, unstable angina, heart failure, respiratory failure, diabetes with renal failure, stroke and joint pain etc) 7. Hospitalization is scheduled during the study period 8. New nutritional or exercise therapy is scheduled during the study period for different purposes from that of the present study 9. The patient who has to see the attending physician every month or every two months for other reasons than CPAP management 10 Telemedicine intervention has already been started 11. Home oxygen therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of participants who achieved 3% weight reduction within the observational period. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Weight change within the observational period 2. Number of steps within the observational period 3. Office and Home blood pressure 4. Scores of the questionnaires for sleep, activity and dietary habits 5. Number of days that the participants collected the data of their weight, blood pressure and pedometer at home 6. CPAP adherence 7. Blood test (HbA1c,T-cho, HDL-cho,LDL-cho, Liver enzyme) 8. Number of days that the participants achieved their target weight within the observational period | — |
Countries
Japan
Contacts
Public ContactMurase Kimihiko
Graduate School of Medicine, Kyoto University Respiratory Care and Sleep Contorol Medicine
Outcome results
None listed